Edition:
United States

Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,710.00GBp
23 May 2018
Change (% chg)

-40.00 (-1.45%)
Prev Close
2,750.00
Open
2,744.00
Day's High
2,754.00
Day's Low
2,694.00
Volume
295,083
Avg. Vol
241,784
52-wk High
2,840.00
52-wk Low
1,636.00

Select another date:

Mon, Feb 26 2018

BRIEF-Dechra Pharmaceuticals Says HY Revenue Up 11 Pct

* SAYS REPORTED GROUP REVENUE FOR SIX MONTHS ENDED 31 DECEMBER 2017 INCREASED BY 11.2% AT CONSTANT EXCHANGE RATE

BRIEF-Dechra Pharmaceuticals ‍Raises 105 Mln Stg Via Placing

* ‍ANNOUNCES SUCCESSFUL COMPLETION OF PLACING ANNOUNCED EARLIER TODAY​

UK's Dechra to buy Dutch firms AST Farma, Le Vet for $422 million

Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Le Vet for a total of 340 million euros ($422.1 million) in a cash-and-share deal to boost its presence in Europe.

UPDATE 1-UK's Dechra to buy Dutch firms AST Farma, Le Vet for $422 mln

Jan 25 Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Le Vet for a total of 340 million euros ($422.1 million) in a cash-and-share deal to boost its presence in Europe.

UK's Dechra to buy Dutch firms AST Farma, Le Vet for 340 mln euros

Jan 25 Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros ($422.1 million) in a cash and share deal.

BRIEF-Dechra Pharmaceuticals to acquire Ast Farma and Le Vet

* ‍BOARD OF DECHRA, INTERNATIONAL VETERINARY PHARMACEUTICAL BUSINESS, IS PLEASED TO ANNOUNCE THAT IT HAS ENTERED INTO A CONDITIONAL ACQUISITION AGREEMENT TO ACQUIRE AST FARMA AND LE VET FOR A TOTAL CONSIDERATION OF EUR 340.0 MILLION ON A DEBT-FREE AND CASH-FREE BASIS​

Select another date: